MCD Monthly Newsletter
Inside the Free Guide

See how the most common MCD treatments compare

The free comparison guide summarizes findings across 30+ studies covering remission rates, relapse patterns, steroid sparing effectiveness, and common side effects.

Preview of the MCD Treatment Comparison Guide
Written in plain English for patients and caregivers.
View the Free Comparison Guide
What You’ll Receive Each Month

What you receive beyond the free guide

Monthly treatment updates explained for patients

Stay current on new MCD treatment findings, relapse prevention research, patient outcomes, and emerging steroid sparing approaches.

Plain-language explanations

Focused on what actually matters for patients. No medical background required.

Know which treatments are actually worth discussing with your doctor

Treatments, relapse prevention, and long-term management. Explained without overload.

Compare Common MCD Treatments
Who This Newsletter Is For

Who this is for

This newsletter was created for patients and caregivers who want a clearer understanding of Minimal Change Disease.

  • People living with Minimal Change Disease
  • Parents and caregivers supporting someone with MCD
  • Anyone who wants clear, trustworthy updates between appointments

It’s not medical advice. It’s support for better understanding and better conversations with your care team.

Resources Included With Your Subscription

Patient-focused resources at no additional cost

Includes five patient resources
Included with all plans · Designed to help you feel confident right away

New Diagnosis Survival Guide

A short, practical guide to what the first year with MCD often looks like: key milestones, early decisions, and questions many patients wish they’d asked sooner.

MCD Specialist Directory

A curated directory to help you identify nephrologists with experience treating protein-spilling diseases like Minimal Change Disease.

MCD Treatment Comparison Guide

Compare the medications commonly used to treat Minimal Change Disease and understand remission rates, relapse patterns, steroid sparing effectiveness, and common side effects in real patients.

Research Trial Radar

A regularly updated list of clinical trials actively recruiting MCD patients, making it easier to explore emerging options with appropriate medical supervision.

The MCD Crystal Ball

A summary of 1-, 5-, and 10-year remission and relapse patterns observed in real patients, helping you plan with greater confidence.

Simple Pricing

One simple plan

Included plan
Everything included

Gold

For patients who want to stay current on new treatments without spending hours reading medical studies.
$5/month
Free 30-day trial
Get the Free Comparison Guide
Full access during the trial · Cancel anytime
Everything included:
Save hours every month
Each issue distills dozens of research papers into the 8–12 developments that actually matter for patients, saving you hours every month reviewing research you’d never have time to read.
Understand your options quickly
Plain-language summaries you can skim in minutes. No medical background required.
Feel prepared for appointments
Each issue includes a short list of important questions that can help you prepare for your next nephrologist appointment.
Free trial available for new subscribers

Try It Without Risk

You don’t need to commit upfront.

All new subscribers receive a free 30-day trial, with full access to the latest newsletter issue, the complete archive, and all included resources.

If it’s not helpful for your situation, you can cancel. No pressure.

Start your free trial today
Free 30-day trial
Cancel anytime

A Final Reassurance

Living with a rare condition is hard enough. Finding clear, trustworthy information shouldn’t be.

If this newsletter doesn’t help you feel more informed or prepared, you don’t have to keep it.

But if it saves you time, reduces uncertainty, or helps you ask better questions then it’s doing its job.

Get the Free Comparison Guide and read your first issue
No pressure · Full access during trial · Cancel anytime
Frequently Asked Questions

Before you decide

Before you decide, here are answers to a few common questions people have when considering the newsletter.

Is there really that much new research on Minimal Change Disease?

Yes, more than most patients realize. On average, over 30 new studies related to Minimal Change Disease are published each month across nephrology journals and related research areas. Between two routine appointments, that’s roughly 180 studies you likely never hear about. Reading them all would take 45+ hours, and most aren’t written with patient relevance in mind. The newsletter exists to filter what’s new, explain what actually matters for patients, and ignore what doesn’t meaningfully affect care.

Why pay for this when information is available online for free?

You can find information online, but staying current is time-consuming, expensive, and difficult to interpret. Many of the newest studies are published in medical journals that require paid access, and the papers themselves are dense and written for specialists, not patients. Reading and evaluating them takes significant time. Subscribers value the newsletter because it provides clear, quick summaries that highlight what actually matters, without needing to sift through paywalls, jargon, or conflicting interpretations.

Is this medical advice?

No. The newsletter is for education and understanding only. It’s designed to help you make sense of information and have better conversations with your healthcare team, not replace medical care or professional advice.

Can I cancel anytime?

Yes. Every subscription starts with a full free trial, and you can cancel at any point, during the trial or afterward, with no penalties or hoops. There’s no long-term commitment. Subscribers renew at an average monthly rate of 98%, but the decision is always yours. If it’s not helpful for your situation, you’re free to cancel whenever you want.

Who is this written for?

The newsletter is written specifically for patients and caregivers. Content is selected and explained with patient decision-making, quality of life, and clarity in mind, not academic prestige or marketing goals.

Free 30-day trial
Compare relapse rates, side effects, and treatment outcomes
Start Free Trial